| Patents for C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018) |
|---|
| 11/22/2006 | CN1285572C Cannabinod receptor ligands |
| 11/15/2006 | CN1863814A Process for the preparation of 7-alpha-methylsteroids |
| 11/14/2006 | CA2258681C Process for the preparation of 17-esters of 9.alpha.,21-dihalo-pregnane-11.beta.,17.alpha.diol-20-ones |
| 11/02/2006 | WO2006115304A1 Agent for treating neuropathic pain |
| 11/02/2006 | EP0973534B1 Plant extracts having appetite suppressant activity |
| 10/25/2006 | EP1326617B9 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma |
| 10/18/2006 | EP0914165B1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms |
| 10/18/2006 | CN1849125A Therapeutic agent for ageing macular degeneration |
| 10/17/2006 | CA2231185C Preparation of ester derivatives of steroids |
| 10/11/2006 | EP1709063A2 Glycosylated steroid derivatives with anti-migratory activity |
| 09/21/2006 | US20060211857 6,7-Oxygenated steroids and uses related thereto |
| 09/19/2006 | US7109187 Estrogenic compounds as anti-mitotic agents |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/14/2006 | DE102005009194A1 Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid A process for producing polymorphic stable triamcinolone acetonide |
| 09/13/2006 | CN1830992A Process for producing intermediate products with 9, 11 double bond of methylprednisolone series products |
| 08/30/2006 | CN1824672A Technological method of separating and producing cortin kind medicine intermediate dehydrogen substance |
| 08/30/2006 | CN1824671A Production method of dexamethasone series product 16,17-bibone intermediate |
| 08/30/2006 | CN1824670A Production method of prednisone hydrolysate |
| 08/29/2006 | US7098328 Method for the preparation of 6α-fluoro corticosteroids |
| 08/24/2006 | WO2006032885A3 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 08/23/2006 | CN1821263A Intermediates for 16 beta -methyl steroids |
| 08/23/2006 | CN1821258A C22 carbanyl steroid compound, synthetic method and its use |
| 08/17/2006 | US20060183727 Estrogenic compounds as anti-mitotic agents |
| 08/10/2006 | US20060178520 Process for preparing medrogestone |
| 08/08/2006 | US7087591 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/02/2006 | EP1326617B1 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma |
| 08/02/2006 | CN1810825A Momertasone furoate intermediate 21-hydroxyl preparing process |
| 07/27/2006 | WO2006077209A1 Method for preparing medrogestone |
| 07/27/2006 | WO2005067673A3 Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof |
| 07/27/2006 | US20060166955 Production process for 16-dehydropregnenoneol and its analogs |
| 07/27/2006 | CA2595317A1 Method for preparing medrogestone |
| 07/20/2006 | US20060159779 treating Type II diabetes by administering a foodstuff or beverage containing a dried extract of a plant of the genus Hoodia; trigyleride; 3-0-[-.beta.-D-thevetopyranosyl-(1-4)-.beta.-D-cymaropyranosyl-(1-4)-.beta.-D-cymaropyranosyl]-12.beta.-0-tigloyloxy-14-hydroxy-14.beta.-pregn-50-ene-20-one |
| 07/19/2006 | CN1803825A Method for synthesizing pregnensteroid compound |
| 07/18/2006 | US7078057 Heating with carrier; mixtur eof fine and coarse particle sizes |
| 07/06/2006 | US20060149045 Steroid compounds with anti-tumor activity |
| 07/06/2006 | US20060148773 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; benign prostatic hyperplasa; cardiovascular disorders; acne |
| 07/05/2006 | EP1248626B1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/04/2006 | US7071328 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21 oh-6op) |
| 06/29/2006 | US20060140816 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/20/2006 | US7064116 GABAA modulating neurosteroids |
| 06/14/2006 | EP1669075A1 Therapeutic agent for ageing macular degeneration |
| 06/14/2006 | CN1786014A Synthesis method of cortin |
| 06/06/2006 | US7057045 oxidation with potassium permanganate to cleave oxazolidinedione ring in methanol solvent, and reacting with potassium t-butoxide in dimethylformamide to deblock; testosterone-5 alpha -reductase inhibitors, for treatment of hyperandrogenic disorders |
| 05/30/2006 | US7053076 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 05/25/2006 | US20060111577 Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| 05/25/2006 | US20060111332 Process and intermediates to prepare17beta-hydroxy-7alpha-methyl-19-nor-17alpha-pregn -5(10)-en-20-yn-3-one |
| 05/24/2006 | CN1777618A 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/10/2006 | CN1769293A High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 05/09/2006 | US7041839 Therapy for hormone sensitivity disease; side effect reduction; anticancer agents |
| 05/09/2006 | US7041318 Fluid energy milling a crystalline material using a milling fluid comprising helium at reduced temperature; crystalline triamcinolone acetonide for inhalation, for example |
| 05/03/2006 | CN1767828A Medicinal composition |
| 04/26/2006 | CN1763067A Dexamethasone sodium phosphate crystal form and its crystallization preparation method |
| 04/25/2006 | US7033616 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use |
| 04/20/2006 | WO2006041121A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | CA2584169A1 Remedies/preventives for chronic skin disease |
| 04/19/2006 | CN1252081C Intermediate for preparation of 16 Beta-methyl steroids |
| 04/18/2006 | US7030157 Hormone replacment therapy; anticancer agent; sexual disorders |
| 04/18/2006 | CA2150738C Process for preparing a 16.beta.-methyl steroid and new intermediates |
| 04/12/2006 | EP1645266A1 Aqueous suspension for nasal drops |
| 04/12/2006 | CN1757649A Synthesis of intermediate 21 position halogenated compound for mometasone furate, and its application |
| 04/12/2006 | CN1250562C Process for preparing hydrocortisone acetate |
| 03/30/2006 | WO2006032885A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/30/2006 | CA2576614A1 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/29/2006 | EP1640009A1 Estrogenic compounds as antimitotic agents |
| 03/29/2006 | CN1753905A Method of obtaining 17alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione |
| 03/29/2006 | CN1247610C 23 position heteroatom substituted analogue of tiger's eye rohdea saponin OSW-1 kind saponin and its synthesis method and use |
| 03/22/2006 | CN1750870A Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 03/15/2006 | EP1633367A2 Antiangiogenic agents |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/08/2006 | CN1745090A Steroid compounds with anti-tumor activity |
| 02/16/2006 | US20060035876 Combination therapy of an SODm and a corticosteroid for prevention and/or treatment of inflammatory bone or joint disease |
| 02/08/2006 | EP1622924A2 8$g(b)-vinyl-11$g(b)-( g(v)-substituted)alkyl-estra-1,3,5(10)-trienes |
| 02/02/2006 | WO2005105822A3 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| 01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/11/2006 | EP1613640A2 Method for preparing 17 alpha-acetoxy-11 beta-(4-n,n-dimethylamin ophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| 01/10/2006 | CA2120004C Methylating or ethylating agent and process for 1,4-adding a methyl or ethyl group to an .alpha.,.beta.-unsaturated ketone group |
| 01/05/2006 | US20060002864 Milling process for the production of finely milled medicinal substances |
| 12/21/2005 | EP0713393B1 Estrogenic compounds as anti-angiogenesis agents |
| 12/15/2005 | WO2005030120A3 Antiangiogenic agents |
| 12/07/2005 | EP1602404A1 Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 11/30/2005 | EP1599233A2 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 11/29/2005 | US6969708 Process for the preparation of a high purity composition comprising (7α, 17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 11/23/2005 | EP1598054A2 Method of suppressing appetite |
| 11/23/2005 | EP1328276B1 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 11/23/2005 | CN1699395A Process for preparing perdnisolone derivatives by one-pot method |
| 11/22/2005 | US6967195 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent |
| 11/16/2005 | CN1227259C Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
| 11/10/2005 | WO2005105822A2 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| 11/03/2005 | US20050245496 Mixture with carrier; dosage units; prevent ovulation; immonomoderator |
| 11/02/2005 | CN1692122A New etonogestrel esters |
| 10/26/2005 | EP1265618B1 Anaesthetic compositions comprising alfaxalone |
| 10/06/2005 | WO2005058934A3 Glycosylated steroid derivatives with anti-migratory activity |
| 10/06/2005 | US20050222113 New etonogestrel esters |
| 10/05/2005 | CN1221563C Production method of 16-dehydro pregnealcoholketone and its same kind compound |
| 09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
| 09/21/2005 | EP1444550B1 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 09/21/2005 | CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |